Matthew Autterson is a Mover and Shaker in the Business World

Matthew Autterson is employed by CNS Bioscience, Inc. He has taken on the roles of Chief Executive Officer (CEO), President and Board Member. He started in the professional field with First Trust Corporation, which is a subsidiary of Fiserv. Autterson’s educational background includes earning a Bachelor of Arts (B.A.) in Finance from Michigan State University in 1980. He also attended the University of Denver Graduate Tax Program.

After his time at First Trust, Autterson joined a group and formed a new charter for Colorado State Trust Company. The new company was a subsidiary of a New York based financial services company called Integrated Resources, Inc, becoming the President in 1986. The company grew and was acquired by Broad, Inc. The company soon was renamed Sun America, Inc and Sun America was acquired in 1998 by AIG for more than $15 billion.

Matthew Autterson is a member of the Colorado business community and a member of the Board of Director’s of FAB (Falci Adaptive Biosystems). As a philanthropist, Autterson’s interests are represented by FAB. Autterson is a former member of the Young Presidents Organization and World Presidents Organization. He also took on leadership roles with the Denver Zoological Foundation and the Denver Zoo, the chair of the Board of Directors of Denver Hospice and the Webb-Waring Foundation.

His work with the organizations he has been affiliated with has allowed him to give back to his community. He has received much goodness throughout his life and wishes to return some of that to the world he lives in. He wants to leave his neighborhood and community a better place for all. Everyone deserves a helping hand and the organization’s he has worked with has given him the chance to improve society for all.

CNS Bioscience, Inc. was founded in 21013 and is a clinical stage medication development company that focuses on neuropathic pain. In his role with CNS, he provides the necessary leadership and inspiration to develop first class drugs to help the medical industry. His background has given him a wide range of experience to take on the roles for which he has undertaken.